Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines

Personalized dendritic cell-based tumor immunotherapy

Clinical applications of a peptide-based vaccine for glioblastoma

Dendritic cell vaccines for brain tumors

Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies

Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients

Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer

Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors

[The case of tumor escape mechanism by changing their tumor-associated antigens]